Safety and efficacy of ruxolitinib cream for the treatment of vitiligo: A randomised controlled trial secondary analysis at 3 years
Saved in:
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Book |
Published: |
Wiley,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_1a70a9b053964dc19db7e2e4dceb7cd6 | ||
042 | |a dc | ||
100 | 1 | 0 | |a John E. Harris |e author |
700 | 1 | 0 | |a Amit G. Pandya |e author |
700 | 1 | 0 | |a Mark Lebwohl |e author |
700 | 1 | 0 | |a Iltefat H. Hamzavi |e author |
700 | 1 | 0 | |a Pearl Grimes |e author |
700 | 1 | 0 | |a Alice B. Gottlieb |e author |
700 | 1 | 0 | |a Howard L. Sofen |e author |
700 | 1 | 0 | |a Angela Y. Moore |e author |
700 | 1 | 0 | |a Mingyue Wang |e author |
700 | 1 | 0 | |a Deanna Kornacki |e author |
700 | 1 | 0 | |a Kathleen Butler |e author |
700 | 1 | 0 | |a David Rosmarin |e author |
245 | 0 | 0 | |a Safety and efficacy of ruxolitinib cream for the treatment of vitiligo: A randomised controlled trial secondary analysis at 3 years |
260 | |b Wiley, |c 2024-12-01T00:00:00Z. | ||
500 | |a 2690-442X | ||
500 | |a 10.1002/ski2.404 | ||
546 | |a EN | ||
690 | |a Dermatology | ||
690 | |a RL1-803 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Skin Health and Disease, Vol 4, Iss 6, Pp n/a-n/a (2024) | |
787 | 0 | |n https://doi.org/10.1002/ski2.404 | |
787 | 0 | |n https://doaj.org/toc/2690-442X | |
856 | 4 | 1 | |u https://doaj.org/article/1a70a9b053964dc19db7e2e4dceb7cd6 |z Connect to this object online. |